Retractable Technologies (RVP)

Executive Summary

Retractable Technologies is a US-based medical device company focused on improving healthcare worker safety through its innovative retractable syringe and needle technology. Founded in 1994, the company's products feature passive, single-handed activation that retracts the needle into the syringe barrel immediately after use, reducing needlestick injuries and medication waste. With a portfolio of three commercial products, Retractable Technologies is publicly traded under the ticker RVP. The company's valuation stands at approximately $21.2 million, reflecting its position in the niche but critical market for safety-engineered medical devices. The company's technology is particularly relevant in light of increasing regulatory focus on healthcare worker protection and infection control. Retractable Technologies continues to focus on domestic and international market expansion, leveraging its patented retraction technology to differentiate itself from traditional syringe manufacturers. The company's financial performance is characterized by stable revenue from existing products, though growth opportunities may arise from new product introductions or strategic partnerships.

Upcoming Catalysts (preview)

• Q2 2026FDA clearance of next-generation retractable syringe70% success
• Q3 2026Partnership or distribution agreement with major healthcare supplier50% success
• Q4 2026Announcement of new manufacturing or supply chain expansion60% success